Filing Details
- Accession Number:
- 0001209191-20-062397
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-08 20:50:15
- Reporting Period:
- 2020-12-08
- Accepted Time:
- 2020-12-08 20:50:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1671858 | Silverback Therapeutics Inc. | SBTX | Pharmaceutical Preparations (2834) | 811489190 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1831967 | Jonathan Piazza | C/O Silverback Therapeutics, Inc. 500 Fairview Avenue N, Suite 600 Seattle WA 98109 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-08 | 11,904 | $21.00 | 11,904 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The shares were purchased in the Issuer's initial public offering.
Billionaire Hedge Funds
